Abstract:<p>The current widespread of COVID-19 all over the world, which is caused by SARS-CoV-2 virus, has again emphasized the importance of development of point-of-care (POC) diagnostics for timely prevention and control of the pandemic. Compared with labor- and time-consuming traditional diagnostic methods, POC diagnostics exhibit several advantages such as faster diagnostic speed, better sensitivity and specificity, lower cost, higher efficiency and ability of on-site detection. To achieve POC diagnostics, developing POC detection methods and correlated POC devices is the key and should be given top priority. The fast development of microfluidics, micro electro-mechanical systems (MEMS) technology, nanotechnology and materials science, have benefited the production of a series of portable, miniaturized, low cost and highly integrated POC devices for POC diagnostics of various infectious diseases. In this review, various POC detection methods for the diagnosis of infectious diseases, including electrochemical biosensors, fluorescence biosensors, surface-enhanced Raman scattering (SERS)-based biosensors, colorimetric biosensors, chemiluminiscence biosensors, surface plasmon resonance (SPR)-based biosensors, and magnetic biosensors, were first summarized. Then, recent progresses in the development of POC devices including lab-on-a-chip (LOC) devices, lab-on-a-disc (LOAD) devices, microfluidic paper-based analytical devices (<em>μ</em>PADs), lateral flow devices, miniaturized PCR devices, and isothermal nucleic acid amplification (INAA) devices, were systematically discussed. Finally, the challenges and future perspectives for the design and development of POC detection methods and correlated devices were presented. The ultimate goal of this review is to provide new insights and directions for the future development of POC diagnostics for the management of infectious diseases and contribute to the prevention and control of infectious pandemics like COVID-19.</p>

Recent advances and clinical application in point‐of‐care testing of SARS‐CoV‐2

Recent Progress on Rapid Diagnosis of COVID-19 by Point-of-care Testing Platforms.

Application Experience of a Rapid Nucleic Acid Detection System for COVID-19

Recent advances in point-of-care testing of COVID-19

Micro/nano biomedical devices for point-of-care diagnosis of infectious respiratory diseases

Recent advances in point of care testing for COVID-19 detection

2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics

Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example

Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus

Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives

Point-of-care testing detection methods for COVID-19

Point of Care Diagnostic Devices for Rapid Detection of Novel Coronavirus (SARS-nCoV19) Pandemic: A Review

Advances in rapid point-of-care virus testing

Point of care detection of COVID-19: Advancement in biosensing and diagnostic methods

The point-of-care-testing of nucleic acids by chip, cartridge and paper sensors

Miniaturized Real-Time PCR systems for SARS-CoV-2 detection at the Point-of-Care

Point-of-care diagnostics for infectious diseases: From methods to devices

Facile biosensors for rapid detection of COVID-19

A Review on Potential Electrochemical Point-of-Care Tests Targeting Pandemic Infectious Disease Detection: COVID-19 as a Reference

Microfluidics-Based POCT for SARS-CoV-2 Diagnostics

Unravelling the diagnostic methodologies for SARS-CoV-2; the Indispensable need for developing point-of-care testing